Kalash Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 6.56 M
as on 17-07-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 10.90 Cr
as on 17-07-2024
- Satisfied Charges ₹ 4.75 Cr
as on 17-07-2024
- Revenue 41.42%
(FY 2021)
- Profit -23.16%
(FY 2021)
- Ebitda 6.04%
(FY 2021)
- Net Worth 13.73%
(FY 2021)
- Total Assets 38.36%
(FY 2021)
About Kalash Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.56 M.
The company currently has active open charges totaling ₹10.90 Cr. The company has closed loans amounting to ₹4.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Seema Gupta and Sonal Nehete serve as directors at the Company.
- CIN/LLPIN
U33119MH2011PTC218712
- Company No.
218712
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2011
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kalash Pharmachem Private Limited offer?
Kalash Pharmachem Private Limited offers a wide range of products and services, including IT, Networking & Automation Solution, IT Consultancy.
Who are the key members and board of directors at Kalash Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Gupta  | Additional Director | Current | |
| Sonal Nehete | Director | 16-Jun-2011 | Current |
Financial Performance of Kalash Pharmachem.
Kalash Pharmachem Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 41.42% increase. The company also saw a substantial fall in profitability, with a 23.16% decrease in profit. The company's net worth Soared by an impressive increase of 13.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kalash Pharmachem?
In 2021, Kalash Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Jalgaon Peoples Co-Op Bank Limited Creation Date: 25 Oct 2021 | ₹0.10 M | Open |
The Jalgaon Peoples Co-Op Bank Limited Creation Date: 30 Apr 2020 | ₹0.88 M | Open |
The Jalgaon Peoples Co-Op Bank Limited Creation Date: 18 Jan 2020 | ₹1.00 Cr | Open |
How Many Employees Work at Kalash Pharmachem?
Unlock and access historical data on people associated with Kalash Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kalash Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalash Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
